The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen
- PMID: 1398921
- PMCID: PMC257439
- DOI: 10.1128/iai.60.10.4080-4087.1992
The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen
Abstract
The humoral immune response of inbred mice to immunization with the glucuronoxylomannan (GXM) of Cryptococcus neoformans was investigated both serologically and in plaque-forming cells (PFCs). The T-helper-cell-independent quality of the GXM was demonstrated by using BALB/c nu/nu mice. Primary and secondary dose responses to three antigenic forms of GXM, (i) the native antigen, (ii) a GXM-bovine serum albumin protein conjugate, and (iii) a cryptococcal whole-cell vaccine, revealed a lack of isotype class switching and anamnestic responses. Both the levels of complement-fixing anti-GXM antibody in serum and the PFC responses in the athymic mice showed no significant differences from those in the wild-type controls. However, T cells are involved in the suppression of the primary response to GXM. When BALB/cBy mice were given rabbit anti-mouse thymocyte serum along with 0.5 microgram of GXM, both antibody levels in serum and PFC responses were significantly increased over those of control mice that received GXM and normal rabbit serum. In addition, T cells were also shown to enhance the primary immune response to GXM. BALB/cBy mice were given GXM and anti-mouse thymocyte serum on day 1. On day 2, the experimental group was given anti-mouse thymocyte serum and the control group was given saline. On day 5, comparison of the PFC responses and anti-GXM antibody titers of the two groups revealed a significant increase in the immune response of the control over the experimental group. The type 2 T-cell-independent quality of GXM was also demonstrated in CBA/cHN xid mice. These mice lack the Lyb+ subset of B cells and are unable to respond to type 2 T-independent antigens but respond normally to type 1 T-independent antigens. Type III pneumococcal polysaccharide, a type 2 T-independent antigen, was used as a negative control, and trinitrophenyl-lipopolysaccharide, a type 1 T-independent antigen, was used as a positive control. The CBA/cHN xid mice failed to respond to either type III pneumococcal polysaccharide or GXM but did not respond to immunization with trinitrophenyl-lipopolysaccharide. BALB/cBy mice responded normally to all three antigens.
Similar articles
-
T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A.Infect Immun. 1993 Apr;61(4):1340-5. doi: 10.1128/iai.61.4.1340-1345.1993. Infect Immun. 1993. PMID: 8095924 Free PMC article.
-
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals.Clin Exp Immunol. 1995 Mar;99(3):425-32. doi: 10.1111/j.1365-2249.1995.tb05568.x. Clin Exp Immunol. 1995. PMID: 7882565 Free PMC article.
-
A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.J Immunol. 2001 Jan 15;166(2):1087-96. doi: 10.4049/jimmunol.166.2.1087. J Immunol. 2001. PMID: 11145689
-
Fungal capsular polysaccharide and T-cell suppression: the hidden nature of poor immunogenicity.Crit Rev Immunol. 2007;27(6):547-57. doi: 10.1615/critrevimmunol.v27.i6.50. Crit Rev Immunol. 2007. PMID: 18197800 Review.
-
Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model.Vaccine. 1996 Jun;14(9):841-4. doi: 10.1016/0264-410x(95)00256-z. Vaccine. 1996. PMID: 8843625 Review.
Cited by
-
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3636-40. doi: 10.1073/pnas.90.8.3636. Proc Natl Acad Sci U S A. 1993. PMID: 8475112 Free PMC article.
-
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Clin Microbiol Rev. 1995 Oct;8(4):515-48. doi: 10.1128/CMR.8.4.515. Clin Microbiol Rev. 1995. PMID: 8665468 Free PMC article. Review.
-
T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A.Infect Immun. 1993 Apr;61(4):1340-5. doi: 10.1128/iai.61.4.1340-1345.1993. Infect Immun. 1993. PMID: 8095924 Free PMC article.
-
Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis.Infect Immun. 2006 Apr;74(4):2161-8. doi: 10.1128/IAI.74.4.2161-2168.2006. Infect Immun. 2006. PMID: 16552046 Free PMC article.
-
Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.Infect Immun. 1995 Aug;63(8):3005-14. doi: 10.1128/iai.63.8.3005-3014.1995. Infect Immun. 1995. PMID: 7622223 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous